z-logo
open-access-imgOpen Access
Activating transcription factor 3 inhibits angiotensin II‑induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine‑rich angiogenic protein 61
Author(s) -
Yu Zhang,
Heming Wu,
Honghui Luo,
Yiqun Luo,
Cong Huang
Publication year - 2022
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr.2022.12852
Subject(s) - cyr61 , atf3 , viability assay , blot , biology , gene knockdown , gene silencing , angiotensin ii , activating transcription factor , ctgf , microbiology and biotechnology , transcription factor , transforming growth factor , fibrosis , signal transduction , chromatin immunoprecipitation , growth factor , cell , cell culture , gene expression , endoplasmic reticulum , endocrinology , unfolded protein response , medicine , receptor , promoter , biochemistry , gene , genetics , blood pressure

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom